Format
Sort by
Items per page

Send to

Choose Destination

Best matches for DØSKELAND AP[au]:

Search results

Items: 21

1.

Release and bioactivity of bone morphogenetic protein-2 are affected by scaffold binding techniques in vitro and in vivo.

Suliman S, Xing Z, Wu X, Xue Y, Pedersen TO, Sun Y, Døskeland AP, Nickel J, Waag T, Lygre H, Finne-Wistrand A, Steinmüller-Nethl D, Krueger A, Mustafa K.

J Control Release. 2015 Jan 10;197:148-57. doi: 10.1016/j.jconrel.2014.11.003. Epub 2014 Nov 10.

2.

Divergence in enzyme regulation between Caenorhabditis elegans and human tyrosine hydroxylase, the key enzyme in the synthesis of dopamine.

Calvo AC, Pey AL, Miranda-Vizuete A, Døskeland AP, Martinez A.

Biochem J. 2011 Feb 15;434(1):133-41. doi: 10.1042/BJ20101561.

PMID:
21087208
3.

The proteasome inhibitors bortezomib and PR-171 have antiproliferative and proapoptotic effects on primary human acute myeloid leukaemia cells.

Stapnes C, Døskeland AP, Hatfield K, Ersvaer E, Ryningen A, Lorens JB, Gjertsen BT, Bruserud O.

Br J Haematol. 2007 Mar;136(6):814-28.

PMID:
17341267
4.

Proteomic strategies for individualizing therapy of acute myeloid leukemia (AML).

Sjøholt G, Bedringaas SL, Døskeland AP, Gjertsen BT.

Curr Pharm Biotechnol. 2006 Jun;7(3):159-70. Review.

PMID:
16789901
6.

Ubiquitinated annexin A2 is enriched in the cytoskeleton fraction.

Lauvrak SU, Hollås H, Døskeland AP, Aukrust I, Flatmark T, Vedeler A.

FEBS Lett. 2005 Jan 3;579(1):203-6.

7.

The binding of tyrosine hydroxylase to negatively charged lipid bilayers involves the N-terminal region of the enzyme.

Thórólfsson M, Døskeland AP, Muga A, Martínez A.

FEBS Lett. 2002 May 22;519(1-3):221-6.

8.
9.

Conjugation of phenylalanine hydroxylase with polyubiquitin chains catalysed by rat liver enzymes.

Døskeland AP, Flatmark T.

Biochim Biophys Acta. 2001 Jun 11;1547(2):379-86.

PMID:
11410294
10.

cAMP induces co-translational modification of proteins in IPC-81 cells.

Hovland R, Døskeland AP, Eikhom TS, Robaye B, Døskeland SO.

Biochem J. 1999 Sep 1;342 ( Pt 2):369-77.

11.

Synergistic antiproliferative actions of cyclic adenosine 3',5'-monophosphate, interleukin-1beta, and activators of Ca2+/calmodulin-dependent protein kinase in primary hepatocytes.

Mellgren G, Bruland T, Døskeland AP, Flatmark T, Vintermyr OK, Døskeland SO.

Endocrinology. 1997 Oct;138(10):4373-83.

PMID:
9322953
12.
14.

Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Isolation and characterization of the wild-type enzyme.

Martinez A, Knappskog PM, Olafsdottir S, Døskeland AP, Eiken HG, Svebak RM, Bozzini M, Apold J, Flatmark T.

Biochem J. 1995 Mar 1;306 ( Pt 2):589-97.

15.

Apoptotic cell death analyzed at the molecular level by two-dimensional gel electrophoresis.

Robaye B, Døskeland AP, Suarez-Huerta N, Døskeland SO, Dumont JE.

Electrophoresis. 1994 Mar-Apr;15(3-4):503-10.

PMID:
8055877
17.

Modulation by pterins of the phosphorylation and phenylalanine activation of phenylalanine 4-mono-oxygenase.

Døskeland AP, Haavik J, Flatmark T, Døskeland SO.

Biochem J. 1987 Mar 15;242(3):867-74.

18.

Phenylalanine 4-monooxygenase from bovine liver.

Døskeland AP, Døskeland SO, Flatmark T.

Methods Enzymol. 1987;142:35-44. No abstract available.

PMID:
3600374
19.
20.

Some aspects of the phosphorylation of phenylalanine 4-monooxygenase by a calcium-dependent and calmodulin-dependent protein kinase.

Døskeland AP, Schworer CM, Døskeland SO, Chrisman TD, Soderling TR, Corbin JD, Flatmark T.

Eur J Biochem. 1984 Nov 15;145(1):31-7.

21.

The effect of ligands of phenylalanine 4-monooxygenase on the cAMP-dependent phosphorylation of the enzyme.

Døskeland AP, Døskeland SO, Ogreid D, Flatmark T.

J Biol Chem. 1984 Sep 25;259(18):11242-8.

Supplemental Content

Loading ...
Support Center